Philip K. Yachmetz

Philip K. Yachmetz is a declared insider at 2 companies (senior executive); the most frequent names are Savient Pharmaceuticals Inc and Teligent, Inc. Between 15 February 2006 and 16 July 2021, the trades on record add up to 60 filings.

Market trades split into 1 purchase (€21k) and 33 sales (€1.2M). On balance, insiders were net sellers of €1.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants and 9 option exercises.

The newest entry dates from 20 July 2021: a share grant of €1,057, in Teligent, Inc. The latest purchase dates back some time: it was published 5,517 days ago, on 16 September 2011. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.